Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial. - O'Brien TJ; Borghs S; He QJ; Schulz AL; Yates S; Biton V (Epilepsia, 2020)